Article
Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism.
Pharmacogenetics and genomics - 1 Jan 2018
Tanner Julie-Anne, Zhu Andy Z, Claw Katrina G, Prasad Bhagwat, Korchina Viktoriya, Hu Jianhong, Doddapaneni HarshaVardhan, Muzny Donna M, Schuetz Erin G, Lerman Caryn, Thummel Kenneth E, Scherer Steven E, Tyndale Rachel F
Abstract excerpt
OBJECTIVES: Smoking patterns and cessation rates vary widely across smokers and can be influenced by variation in rates of nicotine metabolism [i.e. cytochrome P450 2A6 (CYP2A6), enzyme activity]. There is high heritability of CYP2A6-mediated nicotine metabolism (60-80%) owing to known and unidentified genetic variation in the CYP2A6 gene. We aimed to identify and characterize additional genetic variants at the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
